ETON

Eton Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$110.43 sample

+1.54 (+1.41%) 1D

Market cap

$675.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-09

Alerts

8

Price$110.43 +13.22% 3M daily closessample

111.3297.54

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: 10% owner
Sep 29INSInsider buy: Chief Executive Officer
Sep 22INSInsider sell: 10% owner
Sep 16INSInsider buy: 10% owner
Sep 09SECDEF 14A filed
Sep 01INSInsider sell: Chief Financial Officer
Aug 21SECDEF 14A filed
Aug 17INSInsider buy: Director

Sign up to see the real ETON record →

Company facts

SEC EDGAR registration

Name: Eton Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +5sample, -100 to +100
Reporting currency: USD

Who is positioning in ETON

sample

Insiders: 9 insider transactions over 90 days, net selling, $751.4M
Congress: 2 members traded over 90 days
Institutions · 13F: 17 funds hold $12.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$39.8B +15.6% y/y

Q4 2024Q3 2026

Inventory$23.3B +11.3% y/y

Q4 2024Q3 2026

Accounts receivable$17.0B +10.0% y/y

Q4 2024Q3 2026

Total debt$44.6B +8.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $436.0B +1.8% 3M
Sample peer B: $595.2B +10.7% 3M
Sample peer C: $440.2B +5.8% 3M
Sample peer D: $135.6B -0.8% 3M
Sample peer E: $294.1B +4.5% 3M